Exatecan Mesylate shows both high potency against a series of 32 malignant cell lines and significant topoisomerase I inhibition in vitro. The anti‐proliferative activity of Exatecan Mesylate is about 6 and 28 times greater than that of SN‐38 or SK&F 10486‐A, respectively.